ESMO Open: news in breast cancer 2019

por Lambertini, Matteo
Publicado en ESMO Open (2020)

ESMO Open special series on new emerging targets in cancer immunotherapy

por Lambertini, Matteo
Publicado en ESMO Open (2020)

Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer

por Lambertini, Matteo, Viglietti, Giulia
Publicado en Oncotarget (2019)

It Is Time to Talk About Fertility and Immunotherapy

por Duma, Narjust, Lambertini, Matteo
Publicado en Oncologist (2020)

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

por Del Mastro, Lucia, Lambertini, Matteo
Publicado en Oncologist (2015)

The burden of breast cancer from China to Italy

por Levaggi, Alessia, Poggio, Francesca, Lambertini, Matteo
Publicado 2014

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?

por Poggio, Francesca, Lambertini, Matteo, de Azambuja, Evandro
Publicado en ESMO Open (2018)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

por Lambertini, Matteo, Viglietti, Giulia, de Azambuja, Evandro
Publicado en ESMO Open (2018)

How I treat metastatic triple-negative breast cancer

por Caparica, Rafael, Lambertini, Matteo, de Azambuja, Evandro
Publicado en ESMO Open (2019)

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

por Lambertini, Matteo, Preusser, Matthias, Zielinski, Christoph C
Publicado en ESMO Open (2019)

Oncofertility and COVID-19—cancer does not wait

por Sirohi, Bhawna, Rohatgi, Tanya Buckshee, Lambertini, Matteo
Publicado en Ecancermedicalscience (2020)

Fertility issues in young breast cancer patients: what women want

por Lambertini, Matteo, Pinto, Ana Catarina, Del Mastro, Lucia
Publicado 2014

Twenty years of anti-HER2 therapy-associated cardiotoxicity

por Pondé, Noam F, Lambertini, Matteo, de Azambuja, Evandro
Publicado en ESMO Open (2016)

Oncofertility counselling in premenopausal women with HER2-positive breast cancer

por Lambertini, Matteo, Demeestere, Isabelle, Viglietti, Giulia, de Azambuja, Evandro
Publicado en Oncotarget (2019)

ESMO Leaders Generation Programme: an alumni insight

por Arruda, Leticia De Mattos, Criscitiello, Carmen, Lambertini, Matteo, Argiles, Guillem
Publicado en ESMO Open (2018)

Follow‐up strategies for women treated for early breast cancer

por Moschetti, Ivan, Cinquini, Michela, Lambertini, Matteo, Levaggi, Alessia, Liberati, Alessandro
Publicado en Cochrane Database Syst Rev (2016)

Highlights from the San Antonio Breast Cancer Symposium (SABCS) 2019

por Witzel, Isabell, Lambertini, Matteo, Balic, Marija, Wuerstlein, Rachel, Müller, Volkmar
Publicado en Breast Care (Basel) (2020)

Breast cancer screening of mutation carriers in the era of COVID‐19 pandemic

por Toss, Angela, Lambertini, Matteo, Punie, Kevin, Grandi, Giovanni, Cortesi, Laura
Publicado en Int J Cancer (2020)

Fertility counseling of young breast cancer patients

por Lambertini, Matteo, Anserini, Paola, Levaggi, Alessia, Poggio, Francesca, Del Mastro, Lucia
Publicado 2013

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

por Lambertini, Matteo, Richard, François, Nguyen, Bastien, Viglietti, Giulia, Villarreal-Garza, Cynthia
Publicado en Clin Med Insights Reprod Health (2019)